Journal article
The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study
Abstract
A large Canadian cohort was studied over 10 years to see if proton pump inhibitor (PPI) use increased the risk of sustaining a fragility fracture. We found an increased risk of fracture in individuals who used PPIs. The risk remained after controlling for other known fracture risk factors.IntroductionMultiple retrospective studies have linked proton pump inhibitor use with increased risk of fragility fracture. We prospectively studied the …
Authors
Fraser L-A; Leslie WD; Targownik LE; Papaioannou A; Adachi JD; CaMos Research Group
Journal
Osteoporosis International, Vol. 24, No. 4, pp. 1161–1168
Publisher
Springer Nature
Publication Date
4 2013
DOI
10.1007/s00198-012-2112-9
ISSN
0937-941X